These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6824562)

  • 1. The pharmacokinetics of mianserin.
    Shami M; Elliott HL; Kelman AW; Whiting B
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):313S-322S. PubMed ID: 6824562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute bioavailability of mianserin tablets and solution in healthy humans.
    Timmer CJ; Pourbaix S; Desager JP; Sclavons M; Harvengt C
    Eur J Drug Metab Pharmacokinet; 1985; 10(4):315-23. PubMed ID: 3830718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of age on mianserin pharmacokinetics.
    Altamura AC; Melorio T; Invernizzi G; Gomeni R
    Psychopharmacology (Berl); 1982; 78(4):380-2. PubMed ID: 6818603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of mianserin in elderly depressed patients.
    Maguire K; McIntyre I; Norman T; Burrows GD
    Psychiatry Res; 1983 Apr; 8(4):281-7. PubMed ID: 6576394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic study of mianserin.
    Maguire KP; Norman TR; Burrows GD; Scoggins BA
    Eur J Clin Pharmacol; 1982; 21(6):517-20. PubMed ID: 7075657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of mianserin after single dose and at steady-state in depressed elderly patients.
    Dawling S; Ford S; Ariyanayagam P; O'Neal H; Lewis RR
    Clin Pharmacokinet; 1987 Jan; 12(1):73-8. PubMed ID: 3816006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mianserin kinetics in depressed patients.
    Hrdina PD; Lapierre YD; McIntosh B; Oyewumi LK
    Clin Pharmacol Ther; 1983 Jun; 33(6):757-62. PubMed ID: 6851406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of metapramine (19560 RP) in man after infusion and intravenous injection.
    Sumirtapura YC; Leroux Y; Komar AR; Cano JP; Gaillot J
    Eur J Clin Pharmacol; 1983; 25(5):673-7. PubMed ID: 6662165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of diltiazem after intravenous and oral administration.
    Hermann P; Rodger SD; Remones G; Thenot JP; London DR; Morselli PL
    Eur J Clin Pharmacol; 1983; 24(3):349-52. PubMed ID: 6861848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance.
    Ljungberg B; Nilsson-Ehle I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):515-20. PubMed ID: 2504591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorazepam kinetics in the elderly.
    Greenblatt DJ; Allen MD; Locniskar A; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1979 Jul; 26(1):103-13. PubMed ID: 36252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
    Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimipramine kinetics and absolute bioavailability: use of gas-liquid chromatography with nitrogen-phosphorus detection.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Mar; 35(3):348-53. PubMed ID: 6697642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mianserin pharmacokinetics and behavior in hyperkinetic children.
    Winsberg BG; Camp-Bruno JA; Vink J; Timmer CJ; Sverd J
    J Clin Psychopharmacol; 1987 Jun; 7(3):143-7. PubMed ID: 3597800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of spiramycin in man.
    Frydman AM; Le Roux Y; Desnottes JF; Kaplan P; Djebbar F; Cournot A; Duchier J; Gaillot J
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():93-103. PubMed ID: 3182451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanism for mianserin induced neutropenia associated with saturable elimination kinetics.
    O'Donnell JL; Sharman JR; Begg EJ; Colls BM; Moller PW
    Br Med J (Clin Res Ed); 1985 Nov; 291(6506):1375-6. PubMed ID: 3933676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the elimination of mianserin in elderly patients.
    Begg EJ; Sharman JR; Kidd JE; Sainsbury R; Clark DW
    Br J Clin Pharmacol; 1989 Apr; 27(4):445-51. PubMed ID: 2719901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mianserin metabolites.
    Altamura AC; Melorio T
    Br J Clin Pharmacol; 1983 Aug; 16(2):201-3. PubMed ID: 6615696
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of ciprofloxacin in the elderly.
    Bayer A; Gajewska A; Stephens M; Stark JM; Pathy J
    Respiration; 1987; 51(4):292-5. PubMed ID: 3659579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and dose proportionality of cefmetazole in healthy young and elderly volunteers.
    Borin MT; Peters GR; Smith TC
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1944-8. PubMed ID: 2291659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.